BioInno has Complete Round A Financing and Received Nearly 0.2 Billion Yuan.
![](http://nwzimg.wezhan.cn/contents/sitefiles2037/10186639/images/29513265.jpeg)
CDMO外包服务和
无血清细胞培养基业务快速发展,
国际新锐崭露头角
投资者说
关于杭州泰鲲
关于兴业国信
![](http://nwzimg.wezhan.cn/contents/sitefiles2037/10186639/images/29513262.png)
Created on:2021年12月21日 10:25
ꄘPV:0
BioInno Bioscience Co., Ltd.
Enable Patients to Use Advanced Biopharmaceuticals at an Affordable Price.
Product & Services
About us